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T cell activation requires two distinct signals. The first is delivered through the antigen-specific 
T cell receptor (TCR), and the second is provided by costimulatory molecule(s) present on the 
surface of the antigen-presenting cell (APC). Stimulation of T helper type 1 T cell clones through 
the TCR in the absence of the costimulatory activity results in a lack of interleukin 2 (IL-2) 
secretion and proliferation, and the induction of a long-lived state of nonresponsiveness,  termed 
anergy. In this study, we have examined the transcription factors involved in IL-2 gene expression 
that are expressed after stimulation of normal T cell clones through the TCR with and without 
engagement of the necessary costimulatory molecule(s). Antigen-specific activation of the clones 
results  in the induction of a similar pattern of transcription factors that have been previously 
shown to regulate IL-2 expression.  In contrast, antigen presentation by chemically fixed APC, 
a condition that results  in T  cell anergy,  induces neither NF-AT nor one of the two NF-IcB 
binding factors. Thus, the failure to express IL-2 during the induction of T cell anergy may be 
attributed to the absence of these two transcription factors. When anergized T cells are restimu- 
lated with antigen and conventional APC, they induce the transcription factors associated with 
IL-2 expression,  but they fail to synthesize measurable IL-2. Taken together, these data indicate 
that the control of IL2 gene expression during anergy induction and during normal stimulation 
of anergized cells are distinct, and suggest the presence of additional regulatory elements in the 
IL-2 gene. 
ntigen'specific T  cell activation requires  corecognition 
of foreign antigen and self-MHC molecules on the sur- 
face of APCs. Soluble protein antigens are internalized by 
APC, intracellularly processed by denaturation and/or pro- 
teolysis, and presented at the cell surface in a stable complex 
with MHC class II molecules. It is this class II:peptide com- 
plex that is recognized by the TCR on CD4 + T  cells (1). 
In addition, T  cell activation requires  a second signal that 
is provided by the APC (2). Recently, several candidate mol- 
ecules expressed by APC have been proposed to function as 
costimulatory molecules for  T  cell  activation.  The  best 
documented case  is  for B7,  the  ligand for  CD28  (3-7), 
but a role for intercellular adhesion molecule (ICAM)-I/LFA-1 
(8),  VCAM-1/VLA-4  (8),  fibronectin/VLA-4/5  (9),  and 
CD2/LFA-3 (10) have also been suggested. 
The requirement for accessory signals is less well estab- 
lished for the Th2 subset of CD4 + T  cells (11), although 
the ability of these cells to provide their own accessory func- 
tion in vitro may mask this requirement (12). In the case 
of Thl cells, there appears to be a strict requirement for this 
accessory function. Stimulation of Thl T cell clones through 
the TCR in the absence of costimulatory signals results in 
low levels of IFN-3,  and IL-3 expression,  a failure to tran- 
scribe and secrete IL-2, and a failure to proliferate.  Further- 
more, er,:agement of the T cell receptor in the absence of 
approprh:~ second signals can lead to clonal inactivation, and 
a long-lived state of anergy (2, 13-15). Experimentally, anergy 
can be induced by stimulation of T cell clones with chemi- 
cally fixed, conventional APCs and antigen (13), purified class 
II MHC-peptide complexes inserted into planar membranes 
(15), nonconventional APCs, such as islet cells (16) or ker- 
atinocytes (17), or by stimulation with antibodies directed 
against the TCR/CD3 complex (11, 18). Once anergized, 
Thl clones will remain viable and will proliferate  to exoge- 
nous Ib2, but they will not synthesize Ib2 nor proliferate 
when stimulated with nominal antigen and competent APCs 
(2,  14). 
In this report, we have examined the expression of some 
of the nuclear factors that regulate the transcription of the 
II.-2 gene during T cell anergy induction and during restimu- 
lation of anergized cells. We have focused our analysis on the 
IL-2 gene for two reasons. First, the expression of II.-2 is crit- 
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the expression  of I1:2 is strictly dependent on the presence 
of accessory molecules during T cell activation, and appears 
to be completely repressed in anergized cells. The IL-2 pro- 
moter/enhancer has been carefully described (19, 20, 21-26), 
and consists of several regulatory regions, one of which binds 
a T cell-specific transcription factor, NF-AT, another that binds 
a lymphoid specific factor (NF-KB), and other regions that 
bind more general transcription factors. Therefore, we have 
assayed the expression of these factors during stimulation of 
T cells in the presence and absence of accessory function. We 
find that several nuclear factors that have been shown to be 
critical in the regulation of the I1:2  gene are not induced 
by T cells in the absence of accessory molecules.  In contrast, 
once cells are anergized, they can express all of the relevant 
transcription factors after stimulation in the presence of ac- 
cessory function, but do not express  any I1:2.  These data 
suggest that the failure to express I1:2 in the absence of ac- 
cessory molecules may be due to the generation of an incom- 
plete transcription complex at the II.,2 promoter, and sug- 
gest that additional regulatory factors must be involved in 
repressing the I1:2  gene in anergized cells. 
Materials  and Methods 
Cell Lines.  Thl clones, pGL2 and pGL10, were obtained from 
Frank Fitch (27), and are specific  for OVA peptide 323-339 in the 
context of MHC class II, I-A  d. A tryptic digest of OVA was used 
as a source of this peptide (28). Clones were maintained by weekly 
passage with irradiated BALB/cJ splenocytes, 400 /zg/ml OVA 
(Sigma Chemical Co., St. Louis, MO), 20 U/ml Ib2 (Amgen, 
Thousand Oaks, CA), and 200 U/ml IFN-y (Amgen) in DMEM 
supplemented with 10% FCS (Hyclone Laboratories, Inc., Logan, 
UT), 10 mM Hepes, 2 mM glutamine, 0.1 mM nonessential  amino 
acids (Gibco Laboratories, Grand Island, NY), and 50 #M 2-ME 
(Sigma Chemical Co.). Clones were rested a minimum of 8 d post- 
stimulation before use in assays. 
Mice.  BALB/cJ  mice were purchased from Jackson Laborato- 
ries (Bar Harbor, ME) at 6-8-wk  of age. 
Induction of  Anergy.  BALB/cJ  splenocytes  were depleted  of RBC 
by lysis in 17 mM Tris (pH 7.4), 144 mm NH4C1, and of T cells 
by staining with the anti-Thy 1 mAb, G7 (29), and treatment with 
Rabbit complement (Accurate Chemicals, Westbury, NY). These 
T-depleted splenocytes  were fixed in a 1% paraformaldehyde  solu- 
tion in HBSS (Gibco Laboratories) for 20 min at room tempera- 
ture, and washed three times with complete media, incubated 30 
min at 37~  in complete media, and washed three additional times 
with complete media. Thl clones  were Ficoll  purified  and incubated 
overnight  with  a  10-fold excess of paraformaldehyde-fixed, T 
cell-depleted splenocytes plus 250/zg/ml tryptic OVA digest at 
a density of 2.5  x  105 T cells/cm  2 in 100-mm tissue culture dishes 
for 16 h at 37~  T cells were activated  under the same conditions, 
except that irradiated, T cell-depleted splenocytes  (2,000 tad) were 
used as APC. 
Nuclear Extracts.  T cells  were harvested from the tissue culture 
dishes and purified  on a Ficoll-hypaque  gradient to remove  the APCs. 
To further purify the T cell done, the remaining cells were stained 
with anti-lA  d mAb, MKD6 (30), and panned on goat anti-mouse 
IgG (Jackson Immunoresearch Labs, Inc., West Grove, PA) coated 
plates. An aliquot of  purified T cells  were assayed  for anergy induc- 
tion as described below. The remainder were used to isolate nu- 
clear extracts for gel shift assays. Nuclear extracts were made ac- 
cording to the method described  by Fiering  et al., with the exception 
that the extracts were not passed over a P6DG column (31). Briefly, 
cells were allowed to swell in buffer A (10 mM Hepes, pH 7.8, 
15 mM KC1, 2 mM MgC12, 1 mM DTT, 0.1 mM EDTA, 1 mM 
PMSF, 1 #g/ml Antipain, 0.3 #g/ml Leupeptin) for 1 min on ice 
and pelleted for 3 min at 3,000 rpm in a microfuge. Cells were 
then lysed in buffer A plus 0.2%  NP-40. Nuclei were collected 
by centrifugation as above and resuspended in Buffer B (50 mM 
Hepes, pH 7.8, 50 mM KC1, 0.1 mM EDTA, 1 mM DTT, 1 mM 
PMSF, 10% glycerol).  Ammonium sulfate  was added to a final  con- 
centration of 0.3 M, and tubes were rocked in a cold room for 
30 min. Nuclear debris and membranes were pelleted at 100,000 g 
for 10 min in an airfuge (Beckman Instruments Inc., Fullerton, 
CA). Ammonium sulfate was added to the supernatant to a final 
concentration of 1.69 M, and incubated on ice for 5 min. Nuclear 
proteins were pelleted at 50,000g for 5 min in the airfuge. Precipi- 
tated proteins were resuspended in Buffer B and used for gel mo- 
bility shift assays. Protein concentration of extracts was measured 
by the BioRad protein assay  kit (Bio-Rad  Laboratories,  Richmond, 
CA) and checked for integrity by silver stain of SDS/PAGE. 
Gel  Mobility Shift  Assay.  The  oligonucleotides used were 
monomers of the binding sites: NFIb2A (-93 to -63 from human 
IL-2), AP-1 consensus site (32), NF-rB consensus site (33), and 
NF-AT (-285 to -255 from human Ib2). The binding reactions 
were performed essentially as described (34, 35) with the same 
amount of protein in each binding reaction (2-4/xg) in a solution 
consisting of 10 mM Tris, pH 7.5, 50 mM NaC1, 1 mM EDTA, 
1 mM DTT, 5% glycerol, and 4/~g poly dI-dC (Pharmacia Fine 
Chemicals, Piscataway,  NJ). The reactions were incubated at room 
temperature for 20 min with 10,000 cpm double-stranded 32p_ 
labeled oligonudeotides. The samples were electrophoresed  on 4% 
polyacrylamide  gels in a buffer consisting of 25 mM Tris, 190 mM 
glycine, and 1 mM EDTA. 
Lymphokine Assay.  IL-2  was assayed with the indicator line 
CTLL-4 on threefold dilutions of supernatant by the colorimetric 
MTT assay  (36). IL-3  was assayed  with the indicator  cell  line FDCP1- 
IR (37, 38) on threefold dilutions of supernatant by the colori- 
metric MTT assay. IFN-y was assayed by ELISA (39). 
Restimulation ofAnergic T Cells.  2.5  x  104 pretreated T cells 
were incubated in 96-well plates at 37~  with 2.5  x  105 irradi- 
ated BALB/cJ  splenocytes  in varying doses of antigen. After 48 h, 
plates were pulsed with 1/zCi [3H]thymidine/well and harvested 
the next day. Counts  are represented as cpm  x  103. 
Results 
Occupancy of the TCR in the Absence of Accessory Function 
Fails to Induce II.,2 Secretion and Proliferation in Thl Clones.  We 
have used two Thl clones, pGL2 and pGL10, with the same 
peptide (OVA peptide 323-339)  and MHC class II (I-A  ~) 
specificity, but derived from two different strains of mice. 
These clones were incubated overnight with peptide antigen 
presented by either fixed or irradiated T cell-depleted spleno- 
cytes. As expected, stimulation of the T  cells with conven- 
tional, irradiated APCs resulted in vigorous proliferation and 
lymphokine production of Ib2, -3, and IFN-% but not IL-4 
([27],  Table 1).  The two Thl clones inherently produced 
different levels of the three lymphokines after activation, but 
the patterns observed were similar for each clone. In contrast 
to normal activation, stimulation of the clones with fixed 
APC and antigen resulted in suboptimal production of II:3 
1328  Transcriptional  Regulation of the IL-2 Gene in Anergic T Cells Table  1.  Lymphokine Production and Proliferation of Thl  Clones after Antigen Presentation by Fixed and Irradiated APCs 
Lymphokine 
Cell line  Culture condition  IL-2  IL-3  IFN-3,  IL-4  Proliferation 
U/ml  elm  x  103 
pGL2  Rest  0  4  0  0  0 
Stimulation  10  1,800  5,100  0  264 
Anergy  0  81  150  0  4 
pGL10  Rest  0  4  0  0  0 
Stimulation  76  7,600  14,000  0  360 
Anergy  0  90  470  0  74 
Thl clones were incubated overnight with culture media (rest), irradiated APCs plus 250 #g/ml ova peptide (stimulation), or fixed APCs plus 250 
/~g/ml ova peptide (anergy) and assayed for proliferation by [3H]thymidine incorporation at 48 h. Supernatants were collected at 24 h after stimula- 
tion and assayed for lymphokine production as described  in Materials and Methods. 
and IFN-% but little or no proliferation, and no detectable 
I1:2 (Table 1). Furthermore, as has been previously documented 
for other Thl clones (2, 13-15), antigen presentation by fixed 
APC induced a state of anergy in the T cells resulting in an 
inability to proliferate or produce II:2 in response to restimu- 
lation with conventional APC at any of the antigen doses 
A  pGL2 
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Figure 1.  Induction of nonresponsiveness  of Thl clones by preincuba- 
tion with fixed APCs plus peptide antigen. T cells were incubated over- 
night with culture media alone (rest), irradiated APC plus antigen (stim), 
or fixed APC plus antigen (anergy), purified from APC, and restimulated 
with irradiated APC plus antigen. Data from two independent Thl clones, 
pGL2 (A) and pGL10 (B), are cpm (xl03) after [3H]thymidine incorpo- 
ration at 48 h. The high level of proliferation of the stimulated T  cells 
at low antigen concentration is due to continued proliferation from the 
previous stimulation, cpm of thymidine incorporation in the absence of 
antigen for stimulated pGL2 was 172,185 •  1.63, and for stimulated pGL10 
was 32,401  •  37.51. 
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tested (Fig. 1). The nonresponsive state in these clones was 
shown to be long-lived, as the clones could be rested for at 
least 7-9 d after anergy induction without regaining the ability 
to respond to antigenic stimulation. The anergized cells re- 
main viable throughout this rest period and will proliferate 
equivalently to normal resting T cells in response to exoge- 
nous IL-2 (data not shown). In contrast, both resting cells 
and cells that had been stimulated with irradiated APCs did 
respond to antigen in a dose-dependent manner via prolifera- 
tion and lymphokine production, although in some experi- 
ments (see Fig.  1 A), the activated cells were still prolifer- 
ating  from the previous stimulation.  Thus,  antigen pre- 
sentation by fixed APC results in TCR engagement in the 
absence of accessory function as evidenced by the stimula- 
tion of some lymphokine production without proliferation, 
and the induction of a long-lived anergic state. 
Triggering tkrougk tke TCR in the Presence of  Accessory Func- 
tion Upregulates the Nuclear Factors That Regulate IL,2  Tran- 
sc@tion.  The I/~2 promoter contains several highly conserved 
regions that have been shown to bind transcription factors 
that regulate the level of II-2 expression  (Fig. 2). Much of 
the data describing the IL-2 promoter and the transcription 
factors that regulate it have come from the human  Jurkat (19, 
21, 23, 24) and mouse EL4 (20, 22) T cell tumor lines. Re- 
cently,  GraneUi-Piperno  et al. have shown that these same 
factors are also present in activated human peripheral T lym- 
phocytes (25, 26). To verify that the IL-2 gene was being tran- 
scriptionally regulated similarly in our T cell clones, pGL2 
and pGL10 were stimulated for 16 h with irradiated APCs, 
plus peptide antigen and nuclear extracts were isolated from 
the T cells after purification from the APCs. These extracts 
were then assayed by gel mobility shift for the presence of 
NF-AT, AP-1, Octomer, and NF-KB binding factors (Fig. 3). 
Indeed, these normal T cell clones induced the same overall 
pattern of transcription factors after antigen presentation by 
irradiated splenocytes as has been observed for EL4 andJurkat 
tumor cell lines stimulated by mitogens (19, 20). mRNA 
start 
-285  -2~7  -2~  -242  -2o8  -~88  -~8  -~45  -93  -66 
Figure 2.  Ib2 enhancer with known  protein binding sites. Putative DNA binding proteins are noted above binding  sites (19, 21-24, 32,  56). 
Specifically, NF-AT is significantly upregulated over resting 
levels of little  or no  NF-AT.  In addition,  the AP-1  protein 
is induced  to high levels after activation.  Although  in some 
experiments, the AP-1 protein appeared as two forms on the 
gel mobility shift assay, it was consistently upregulated upon 
both types of stimulation,  and there was no preferential in- 
duction of either form in the stimulated nuclear extracts. The 
Oct-1  protein  generally stayed at ubiquitous  resting  levels, 
but in some experiments, there was a slight induction of this 
nuclear factor (Fig.  3 A).  The Oct-2 protein,  which is nor- 
really present in B cells and is important in Ig gene regula- 
tion (40, 41, 42), was induced slightly in the pGL2 cell line, 
and more fully in the pGL10 cell line. The induction of Oct-2 
was not seen in the stimulated T  cell tumor lines (19, 21-24) 
and  was  slightly  induced  in  the  peripheral  T  lymphocytes 
(25,  26),  and  may be an important  difference between  the 
T  cell clones and the tumor lines. For NF-gB binding factors, 
we identify at least two forms of this factor present in acti- 
vated cells using the consensus NF-gB probe. There is a slower 
migrating  form  that  we refer  to  as B1  (see Fig.  3)  that  is 
Figure 3.  Failure  to induce NF-AT and one form of NF-gB in T cell clones stimulated with fixed APCs and peptide antigen, pGL2 (A) and pGL10 
(B) were stimulated overnight with irradiated or fixed APCs plus 250/xg/ml  OVA peptide, purified from the APCs, and nuclear extracts were made. 
Gel mobility shift assays  were performed on these extracts with the following probes, NF-AT, NF-gB, NFIL-2A, and AP-1. Consensus sites for NF-kB 
and AP-1 were used as probes because several proteins have been reported to bind to the NFIL-2C and NFIL-2B regions and we were interested in 
looking specifically  at NF-kB and AP-1 binding proteins in these cells (19, 20). (FP) Free probe; (R) incubation in culture media; (S) incubation with 
irradiated APC plus OVA peptide; (A) incubation with fixed APC plus OVA peptide. (---) Position of gel shifted complexes. 
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induced to high levels during activation. There is also a faster 
migrating form that we refer to as B2 that is also upregu- 
lated during activation, but at slightly lower levels than is B1. 
Engagement of the TCR in the Absence of  Accessory Function 
Fails to Upregulate Two Nuclear Factors that Are Involved in 11_,2 
Gene Regulation.  To  address  the  molecular  mechanism 
whereby the T cell clones failed to express IL-2 after stimula- 
tion with fixed APCs,  nuclear extracts from these T  cells 
were examined for expression of the same set of DNA binding 
proteins assayed above.  T  cell clones were incubated over- 
night with fixed APCs and peptide antigen, and analyzed 
in parallel with the activated cells described above for the ex- 
pression of NF-AT, AP-1, Octomer, and NF-KB binding pro- 
teins by gel mobility shift assays (Fig.  3). 
Stimulation by fixed APCs induced a profile of transcrip- 
tion factors in our T cell clones that differed from the fully 
stimulated cells in two ways. First, little or no NF-AT was 
induced after engagement of the TCR in the absence of ac- 
cessory function. NF-AT is a T cell-specific factor (21) that 
has been shown to be critical for full IL-2 gene induction. 
In the absence of the distal NF-AT binding region, induction 
of transcription from the IL-2 promoter after transient trans- 
fection into Jurkat cells is ~30%  of maximal, and removal 
of the proximal NF-AT site further reduces the activity of 
the promoter (31). In addition, recent results by Fiering et 
al. indicate that there is a threshold level of NF-AT that must 
be present for transcription to occur (31),  suggesting that 
the small amount of NF-AT produced during fixed APC stim- 
ulation in pGL2 cells (Fig. 3 A) may not be enough to allow 
for the transcription of the I1,-2 gene. 
The second observation that may be involved in preventing 
IL-2 transcription after stimulation with fixed APCs is that 
the faster migrating form of the NF-KB binding factor, B2, 
is not induced, while the slower migrating form, B1, is slightly 
induced. In contrast, both forms are induced in the fully ac- 
tivated state (Fig.  3).  Molitor et al.  have shown that there 
is a family of NF-KB proteins made up of different subunits 
in association with the P55 subunit that are induced after 
stimulation by PMA in Jurkat T cells (43). The various forms 
of NF-KB have been shown to bind with different affinities 
to different promoter regions that contain NF-KB-like  se- 
quences. However, it is not known if these two forms func- 
tion differently in transcriptional regulation. 
It is interesting that the rest of the nuclear factors we ex- 
amined were induced both with TCR occupancy alone, and 
in combination with accessory signals  (Fig. 3). Oct-1 levels 
generally remained at resting levels and Oct-2 was present 
at high levels under both stimulation conditions. Since the 
octomer proteins are involved in the regulation of many other 
genes in the cell, they may be less likely to be influenced with 
TCR signalling.  In addition, AP-1 was also induced to similar 
levels under both conditions of T cell stimulation. In some 
experiments, however, the level of AP-1 produced was slightly 
less with TCtL triggering in the absence of accessory func- 
tion as compared with complete stimulation, but was still 
induced significantly over resting levels (see pGL10 in Fig. 
3 B). Although the levels of octomer binding proteins and 
of AP-1 in T cells stimulated with fixed APCs can vary slightly 
from experiment to experiment as compared with T  cells 
stimulated with irradiated APCs, we have consistently ob- 
served the failure to fully induce NF-AT and the B2 form 
of the NF-KB binding protein after stimulation with fixed 
APC and nominal antigen. Therefore, it appears that the lack 
of costimulatory molecule engagement prevents the induc- 
tion of these two transcription factors. 
NF-AT and NF-KB-B2 Are Not Induced at Any Time after 
Stimulation with FixedAPC.  It was possible that the reason 
why NFoAT and NF-KB-B2 were not present in our nuclear 
extracts at 12-16 hours poststimulation with fixed APC was 
that these factors had peaked earlier and had already declined 
to resting levels by the time the cells were harvested. There- 
fore, T  cells were stimulated with fixed APC and peptide 
antigen for 2,  6, and 16 h  and nuclear extracts were made 
at these times. Proliferative anergy was induced by 6 h  of 
stimulation with fixed APCs (Fig. 4 A), providing evidence 
that TCR engagement had occurred. Analysis of nuclear ex- 
tracts made from these cells showed that both NF-AT and 
the B2 form of NK-KB were induced minimally, if at all, 
at any time after stimulation with fixed APC.  In contrast, 
the B1 form of NF-KB and AP-1 were induced maximally 
at 6 h after stimulation (Fig. 4 B). Thus, the lack of induc- 
tion of NF-AT and NK-KB-B2  throughout the entire 16 h 
after antigen presentation by fixed APC may account for the 
absence of II,-2 gene expression. 
Restimulation of  Nonresponsive Cells Induces the Same Pattern 
of Transc@tion Factor  Expression Associated with Normal T Cell 
Activation, but Does Not Result in 11_,2 Gene Expression.  Once 
anergized, Thl clones will remain viable for extended periods 
of time  (up  to  7-9  d  with  pGL2  and  pGL10)  and  will 
proliferate to exogenous IL-2. However, when restimulated 
with normal APCs, these cells will not express any detect- 
able IL-2 and will not proliferate (see Fig.  1). To determine 
whether the failure to express  NF-AT and/or the B2 form 
of the NF-KB binding factor was permanent in anergized cells, 
we examined the expression of these factors after restimula- 
tion of anergic cells with antigen and conventional APCs 
(Fig. 5). Specifically, T cells were induced to a nonresponsive 
state by incubation overnight with fixed APCs and peptide 
antigen, and then purified from the APCs the next day. The 
nonresponsive T cells were subsequently rested in culture media 
for 2 d. At this time, an aliquot of anergized cells were har- 
vested, and restimulated by incubation for 16 h with irradi- 
ated APCs and peptide antigen. Nuclear extracts were made 
from these anergized and restimulated ceils (ReS), from aner- 
gized cells that were not stimulated (A'),  from completely 
rested cells (R), and from rested cells that had been stimu- 
lated with irradiated APCs and antigen (S). The extracts were 
examined for pertinent transcription factors by gel mobility 
shift assay. 
An aliquot of the cells used to make nuclear extracts were 
tested to confirm that anergy had been induced in these cells 
(Fig. 5 B). When restimulated with irradiated APC and an- 
tigen, the anergized cells failed to synthesize detectable levels 
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sion after TCK occupancy in the absence of accessory  function, pGL2 cells 
were treated for 0, 2, 6, and 16 h with fixed APC and peptide antigen. 
The T cells were purified and analyzed for proliferative anergy (-4) as de- 
scribed in Fig. 1 and for the induction of transcription  factors (B) by gel 
mobility shift assays as described in Fig. 3. 
of IL-2 (data not shown), and to proliferate. Surprisingly,  al- 
though functional anergy had been achieved (Fig.  5 B),  all 
of the nuclear factors associated with IL-2 gene expression, 
Oct-l, Oct-2, AP-1, NF-xB-B1, NF-KB-B2, and NF-AT, were 
induced similarly in both resting and anergized cells that had 
been stimulated in the same manner (Fig. 5 A). More specifi- 
cally, the levels of transcription factor expression in anergized 
cells that had been rested in culture media for 2 d generally 
declined back to resting levels, and were comparably induced 
Figure 5.  Anergized T cells induce the same set of transcription factors 
as resting cells, but fail to proliferate or produce IL-2, when restimulated 
with irradiated APC and antigen. (A) Gel mobility shift assays of pGL2 
cells. T cells were rested in culture media (R), or incubated with irradiated 
APC plus OVA peptide for 16 h (S) as described in Fig. 3. In addition, 
T cells were anergized by incubation  of resting cells with fixed APC plus 
OVA peptide overnight,  purified from the APCs,  and rested in culture 
media for 2 d. Nuclear extracts were made from these cells after the 2 d 
rest period (A'). An aliquot of these same cells were restimulated by incu- 
bation with irradiated APC plus OVA peptide for 16 h and nuclear ex- 
tracts were isolated (ReS).  Gel mobility shift assays were performed  as 
described in Fig. 3. (B) Proliferative response of anergized pGL2 from Fig. 
5 A above. An aliquot of the cells, R and A', used to make nuclear extracts 
above were incubated with irradiated APC and antigen and tested for 
proliferation as described in Fig. 1. Data are cpm x  103 after [3H]thymi- 
dine incorporation  at 48 h. 
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experiment did not increase to quite the same levels as that 
seen after stimulation of resting cells, but in other experi- 
ments, did reach the same high levels seen in stimulated cells. 
In addition, in this experiment, the B2 form of NF-KB ap- 
pears to be slightly higher in rested anergized cells as com- 
pared with rested cells and may be due to a minor fluctuation 
in basal levels of this factor over time in anergized cells. We 
have seen slight  differences in resting levels of the various 
transcription factors in our clone in various experiments and 
this may depend on the length of time the clone has been 
rested since the last stimulation. However, in all experiments, 
we see a comparable induction of all the transcription factors 
in both stimulated rested cells and in restimulated anergized 
cells. Thus, the failure to induce IL-2 gene expression during 
anergy induction and during restimulation of anergized cells 
appears to be controlled by independent mechanisms. These 
results suggest that there may be additional mechanisms that 
regulate Ib2 gene expression during restimulation of non- 
responsive T  cells. 
Discussion 
In this study, we have shown that the failure to express 
IL-2 in T cell clones after antigen presentation by fixed APC 
can be attributed to the lack of  upregulation of the transcrip- 
tion factors NFoAT, and the slower migrating form of the 
NF-KB binding protein, B2. The lack of these factors may 
fail to allow for the assembly of a complete transcriptional 
complex on the IL-2 promoter, in the absence of which the 
IL-2 gene cannot be expressed. In contrast, stimulation of 
the T cells by irradiated APC, a situation that allows for the 
engagement of costimulatory molecules, upregulates the ex- 
pression of the transcription  factors important in inducing 
transcription of the I1.-2 gene. Thus, costimulation appears 
to function directly with TCR engagement in the transcrip- 
tional regulation of the I1.-2 gene in responding T cells. It 
is interesting that although other lymphokines, such as II.-3 
and IFN-y, can be induced by signalling only through the 
TCR, their expression can be greatly enhanced in the pres- 
ence of costimulatory activity. The promoter regions of these 
lymphokines, as well as many others (44), contain an NF-KB 
consensus sequence. Thus, the lower levels of lymphokine 
expression, including I1.-2, -3, and IFN-% after stimulation 
in the absence of accessory function may be attributed to the 
failure to induce the NF-KB-B2 form, and the complete ab- 
sence of II.-2 expression may result  from the failure to ex- 
press NF-AT. 
The failure  to  induce either NF-AT or the NF-KB-B2 
binding protein may be explained by several reasons. First, 
these factors themselves may be under transcriptional and/or 
translational  control, and in the absence of a costimulatory 
signal,  they are not synthesized.  Second, there may be an 
inhibitor that is pre-existing  or newly synthesized,  which 
prevents translocation of these factors to the nucleus or alters 
the protein in some way as to render it transcriptionally inac- 
tive. The inhibitor for NF-KB, IKB, has been described by 
Baeuerle and Baltimore (45) as binding to the NF-KB pro- 
tein in the cytoplasm and releasing it to the nucleus upon 
T cell activation with mitogens.  There has not been an in- 
hibitor described for NF-AT. We do not feel, however, that 
the failure to express these factors during anergy induction 
results from a decrease in the ability of fixed APC to trigger 
the TCR. We know that the TCR has been engaged with 
fixed APCs, because the cells will express some lymphokines, 
and these cells have been functionally anergized. In addition, 
our preliminary results indicate that when we compensate 
for the decrease in the efficiency of antigen presentation by 
fixed cells by adjusting  the concentration of antigen used, 
NF-AT and NF-KB-B2 are still induced significantly greater 
after presentation  by irradiated  APC than by fixed APC. 
There are two situations in which we have found that the 
levels of NF-AT can be varied experimentally with TCR oc- 
cupancy alone. In the first situation,  the TCR is occupied 
not by its specific ligand, but by a mAb to the CD36 chain 
of the TCR,  145-2Cll  (46). At high doses, the anti-CD3 
mAb can cause a nonresponsive state to be induced in T cell 
clones, similar to the state induced by fixed APCs and an- 
tigen. At these same doses, however, T  cells are in a state 
of high dose suppression whereby the cells fail to proliferate 
to the anti-CD3 mAb, as well as to exogenous IL-2 (47, 48). 
In addition, in some Thl clones, incubation on immobilized 
anti-CD3 mAb alone can also stimulate these cells to pro- 
duce IL-2, whereas, TCR engagement by fixed APC and pep- 
tide antigen does not (11, 48). When nuclear extracts were 
examined from cells stimulated with anti-CD3 mAb, we saw 
the induction of significant but suboptimal levels of NF-AT, 
with all other factors, including NF-KB, being induced simi- 
larly when the TCR is engaged by fixed APC and peptide 
antigen (C. Go andJ. Miller, unpublished observations). The 
observed induction of NF-AT in our T cell clones after stim- 
ulation with anti-CD3 mAb is consistent with the observa- 
tion that some Thl clones, including the ones examined in 
this study, can express IL-2 in response to anti-CD3 stimula- 
tion alone, but remain nonresponsive to subsequent stimula- 
tion. In the second situation,  the levels of NF-AT can vary 
considerably depending on the technique used for isolating 
nuclear extracts. For example, in our laboratory, the Digham 
et al. (19) method of  purifying nuclear extracts does not pre- 
serve NF-AT binding ability, even in stimulated cells. Under 
other preparative conditions, NF-AT is extracted inefficiently, 
and we have found that in these cases, apparently similar levels 
of NF-AT are found in activated and anergized cells. In the 
data that we have presented here, we have optimized the ex- 
traction of NF-AT and we are confident that the in vitro data 
reflect a real decrease in the amount of NF-AT produced in 
vivo during TCR occupancy in the absence of accessory func- 
tion in these T  cell clones. 
The lack of NF-AT expression after anergy induction is 
consistent with the model proposed by Granelli-Piperno et 
al. (26) in human primary T cells. Specifically,  they propose 
that the induction of NF-AT activity requires two signals, 
namely PMA and PHA, anti-CD3, or anti-CD28. Similarly, 
in our system, when only one of the signals is given to the 
T cell clone by stimulation with fixed APC, NF-AT binding 
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stimulation with irradiated APC, a high level of NF-AT is 
induced. Both of these systems fit the hypothesis by Flanagen 
et al. (49) that there are two subunits of NF-AT that bind 
together in the nucleus to form a functional DNA binding 
protein, and each of the signals is important in the forma- 
tion of this complex. 
Although NF-AT plays a major role in the transcriptional 
control of the IL-2 gene, the lack of the faster migrating form 
of the NF-KB binding protein, B2, in T cells stimulated by 
fixed APCs may be equally important to the block in IL-2 
expression. The functional role of the two forms of NF-KB, 
B1  and B2,  in transcription have not been elucidated, but 
it is apparent that different cell types express different levels 
of each form and various enhancers can bind each form at 
varying affinities  (43).  In addition, at least two NF-KB-like 
binding regions in the IL-2 promoter have now been identified. 
The first region was identified by in vitro footprinting as the 
NFIL-2C region (19, 20). Two transcription factors,  NF-~B 
and AP-3, have been reported to bind at this region, and have 
very similar consensus binding sequences (33,  50).  Indeed, 
the NFIL-2C binding protein can be competed from its binding 
site by both the consensus sites of NF-KB and AP-3 (data 
not shown), and it is not clear which of these factors, or which 
of the NF-KB forms, are footprinting in this region. How- 
ever, when this site was deleted in IL-2 promoter reporter 
gene constructs in Jurkat T  cells, there was no decrease in 
expression during activation,  as compared with the full length 
promoter (19). These data suggest that the NFI1:2C site may 
not be critical to the upregulation of the IL-2 gene. In con- 
trast, Hemar et al. (51) have recently shown that this region 
is critical in controlling the expression of the I1:2  gene in 
a T  cell line that constitutively expresses  I1:2.  Analysis of 
nuclear extracts from these cells reveals two NF-KB binding 
proteins that gel shift in a pattern that is very similar to that 
seen in our T cell clones. Hemar et al. (51) suggest that the 
slower migrating form may be the NF-KB protein composed 
of the p65-p50 heterodimer, while the faster migrating form 
may be the KBF-1 protein composed of the p50 subunit. The 
NF-KB protein has a higher affinity for the Ig KB binding 
site, whereas the KBF-1 protein has a higher affinity for the 
NFI1:2C  site from the I1:2  promoter. These data suggest 
that KBF-1 may be more important in IL-2 gene regulation 
than NF-KB, and when KBF-1 is not induced during stimu- 
lation of T cell clones by fixed APCs, IL-2 transcription does 
not occur. 
Engagement by B7 by CD28 recently has been implicated 
as an important costimulatory interaction in T  cell activa- 
tion (3-7).  Triggering of CD28 by antibodies or by trans- 
fected cells that express B7 can facilitate stimulation of I1:2 
production in conjunction with anti-CD3 antibodies (4-7). 
Recently two groups have reported that specific nuclear factors 
that bind to the I1:2 promoter near the AP-1 site can be in- 
duced after stimulation of T cells with anti-CD28 antibodies 
(42,  53).  It is interesting that one of these appears to be an 
NF-KB binding protein,  as binding to the CD28 response 
element in the II:2 promoter is competed efficiently by the 
HIV-1 NF-KB site (53).  These data are consistent with our 
finding that in the absence of costimulation, T  cells fail to 
express one of the two NF-KB binding proteins present during 
normal T cell activation and suggest that the NF-KB-B2 form 
may be the critical component involved in regulation of the 
IL-2 gene. Experiments to test whether B7/CD28 engage- 
ment can induce one or both of the missing transcription 
factors are presently underway. 
In contrast to the induction phase of anergy, restimula- 
tion of previously anergized T cells with conventional APCs, 
does induce the normal pattern of transcription factors as- 
sociated with IL-2 expression, although no IL-2 is produced. 
These data suggest the existence of additional mechanisms 
to regulate the IL-2 gene. One possibility is that the IL-2 
mRNA is posttranscriptionally regulated in anergized T cells, 
making it extremely unstable after its induction upon res- 
timulation. Another possibility may be that the control func- 
tions directly on the transcription factors themselves, such 
that these factors retain their DNA binding activity, but are 
modified so that they no longer promote transcriptional ac- 
tivity. Alternatively, a silencer region, such as that recently 
identified by Williams et al. (54), may be involved in down- 
regulating  IL-2  transcription  during  T  cell anergy.  It  is 
interesting that this putative silencer region is thought to 
function during normal T cell activation to shut off IL-2 tran- 
scription. The recent results of DeSilva et al.  (55),  demon- 
strating that inhibition of T cell proliferation during normal 
T cell activation can induce T cell anergy, are consistent with 
a  role  of negative  regulatory  factors  in  T  cell  anergy. 
Specifically,  during T  cell activation, normal proliferation 
of the T cell may dilute out any negative regulatory factor 
induced during the stimulation response, allowing the IL-2 
gene to return to an activatable state. During anergy induc- 
tion, the IL-2 gene is not induced, but the repressor(s) is 
induced normally. The lack of T cell proliferation that results 
from the failure to express IL-2 leads to the establishment 
of a stable, nontranscriptionally active IL-2 gene complex. 
This complex would remain inactive even in the face of acti- 
vation of the normal panel of positive regulatory elements 
associated with IL-2 transcription during restimulation of 
anergized cells. Experiments are in progress to test this model. 
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